Alcresta Therapeutics, INC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersWaltham, MA
SAM.gov UEIYFUTGG4USLE7
Alcresta Therapeutics develops enzyme-based products for rare diseases, specifically addressing fat malabsorption in patients requiring enteral nutrition. The company's product RELiZORB contains iLipase, a patented microbead/enzyme technology designed to break down fat for absorption in patients who are enterally fed at home or in the hospital, often those with exocrine pancreatic insufficiency.
Summarized from the company’s own website
What they make
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Alcresta Therapeutics, INC | Waltham | MA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.